𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer

✍ Scribed by Hideo Inaji; Yoshifumi Komoike; Kazuyoshi Motomura; Tsutomu Kasugai; Yuka Sawai; Masahiko Koizumi; Takayuki Nose; Hiroki Koyama

Publisher
Springer Japan
Year
2002
Tongue
English
Weight
561 KB
Volume
9
Category
Article
ISSN
1340-6868

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Breast-conserving surgery after neoadjuv
Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors
✍ Roman Rouzier; Marie-Christine Mathieu; Lucas Sideris; Esther Youmsi; Radhika Ra πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

## Abstract ## BACKGROUND Randomized trials comparing neoadjuvant versus adjuvant chemotherapy show that primary chemotherapy allows more frequent breast‐preserving surgery even though no survival advantage has been demonstrated. The aim of the current study was to determine the predicting factors

Neoadjuvant chemotherapy in breast cance
Neoadjuvant chemotherapy in breast cancer
✍ H. Charfare; S. Limongelli; A. D. Purushotham πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 2 views
Residual specimen cellularity after neoa
Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer
✍ F. Peintinger; H. M. Kuerer; S. E. McGuire; R. Bassett; L. Pusztai; W. F. Symman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 289 KB πŸ‘ 2 views

## Abstract ## Background Neoadjuvant chemotherapy for breast cancer reduces tumour cellularity, the percentage of the primary tumour area that is composed of invasive tumour cells. Minimal residual tumour cellularity (5 per cent or less of tumour area composed of invasive tumour cells) may be ass

Neoadjuvant chemotherapy in locally adva
Neoadjuvant chemotherapy in locally advanced breast cancer
✍ Singh, Gurpreet; Singh, Deepinder P.; Gupta, Devender; Muralikrishna, Bhavaraju πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 403 KB πŸ‘ 2 views

Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were